USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/27042
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMargine, Rodica-
dc.contributor.authorNacu, Viorel-
dc.date.accessioned2024-04-29T06:56:36Z-
dc.date.available2024-04-29T06:56:36Z-
dc.date.issued2024-
dc.identifier.citationMARGINE, Rodica, NACU, Viorel. Cell vaccines in the treatment of hepatocellular carcinoma. In: Cells and Tissues Transplantation. Actualities and Perspectives: the materials of the nat. scientific conf. with internat. particip., the 2nd ed. Chisinau, March 29-30th 2024: [abstracts]. Chişinău: CEP Medicina, 2024, p. 31. ISBN 978-9975-82-366-1.en_US
dc.identifier.isbn978-9975-82-366-1-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/27042-
dc.description.abstractBackground. Hepatocellular carcinoma is one of the most common forms of cancer globally (sixth most common cancer, in 2020), and represents an essential cause of mortality worldwide (third most common cause of death from cancer etiology), with approximately 905,677 new cases and 830,180 deaths in 2020 without effective treatment methods. Thus, the use of cellular vaccines in the treatment of hepatocellular carcinoma is a new therapeutic approach, aimed at acting on cancer cells and destroying them, by inducing efficient cellular responses mediated by specific antibodies for antigens selectively expressed by the tumor. Aim of study. Studying the effectiveness of cell vaccines in the treatment of hepatocellular carcinoma, to increase the quality and duration of life. Methods and materials. This study is a review of the specialized literature of the last 10 years on the selected topic. Electronic databases were used: NIH (5), Google Academic (2), PubMed (3), Medscape (1). Results. The use of cellular vaccines in the treatment of hepatocellular carcinoma is a new therapeutic vision used by researchers, which appeared and was implemented less than a decade ago, and which is in continuous development, due to the positive results it has. There are several types of cellular vaccines: based on peptides, dendritic cells, based on viral vectors, DNA, mRNA, which have proven their effectiveness following clinical trials on patients. Thus, a meta-analysis of 11 studies including 396 patients reported a cumulative clinical response rate of 15.4% and that DC vaccines were well tolerated, and the survival rate increased in sick patients. Conclusion. Cell vaccines for the treatment of cancer show substantial potential for the successful management and possible prevention of mortality from hepatocellular carcinoma. Cell vaccines need to be researched and applied in practice, especially in clinical trials, to evaluate the safety, efficacy and clinical relevance of these vaccines in cancer patients, to achieve long-term control of tumors and a lasting remission.en_US
dc.language.isoenen_US
dc.publisherCEP Medicinaen_US
dc.relation.ispartofCells and tissues transplantation. Actualities and perspectives. The 2-nd edition. Chisinau, March 29-30th 2024en_US
dc.subjectcellular vaccinesen_US
dc.subjecthepatocellular carcinomaen_US
dc.subjectimmunotherapyen_US
dc.subjectdendritic cell-based vaccinesen_US
dc.subjectpeptide-based vaccinesen_US
dc.subjectmRNA-based vaccinesen_US
dc.subjectDNAen_US
dc.titleCell vaccines in the treatment of hepatocellular carcinomaen_US
dc.typeOtheren_US
Appears in Collections:The Materials of the National Scientific Conference with International Participation, the 2nd edition, Chisinau, March 29-30th 2024: [Abstracts]

Files in This Item:
File Description SizeFormat 
CELL_VACCINES_IN_THE_TREATMENT_OF_HEPATOCELLULAR_CARCINOMA.pdf272.97 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback